Replies to post #23316 on Revive Therapeutics Ltd (RVVTF)

[RioDad]

If raising capital was the ONLY news, I’d be worried, but there are many catalysts with revive that you won’t find in ANY example.

I bought in for the Psychedelic aspects, if Bucillamine fails, RVV is still a winner.

Too many people are looking at penny stocks like they bet on sports.

By the way, Revives Capital raise was part of investors investing into a Psychedelic company, not a Covid play. This point is clear and irrefutable.

[RioDad]

If raising capital was the ONLY news, I’d be worried, but there are many catalysts with revive that you won’t find in ANY example.

I bought in for the Psychedelic aspects, if Bucillamine fails, RVV is still a winner.

Too many people are looking at penny stocks like they bet on sports.

By the way, Revives Capital raise was part of investors investing into a Psychedelic company, not a Covid play. This point is clear and irrefutable.

The price of Revive’s stock has always moved on Psychedelic sector and not the Covid sector.